12.07.2015 Views

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

A <strong>Clinical</strong> <strong>Guide</strong> <strong>to</strong> <strong>Supportive</strong> <strong>and</strong> <strong>Palliative</strong> <strong>Care</strong> <strong>for</strong> <strong>HIV</strong>/<strong>AIDS</strong> • Chapter 3: Assessment of Physical Symp<strong>to</strong>msprescribed <strong>for</strong> pain. 8 Results indicated that nearly 85% of patients with pain were classified asreceiving inadequate analgesic therapy <strong>and</strong> fewer than 8% of the 110 patients who reported“severe” pain were prescribed a “strong” opioid (e.g., morphine), as would usually be suggestedin published26guidelinespicas<strong>for</strong> treatment of severe pain. 8Thus it is clear that many symp<strong>to</strong>ms are prevalent in persons with <strong>HIV</strong>-related illness, especiallyin persons with advanced <strong>HIV</strong>-related disease. In addition, there is evidence <strong>to</strong> suggest that thehigher the number of symp<strong>to</strong>ms, the greater the experience of distress. It is common <strong>for</strong> manysymp<strong>to</strong>ms <strong>to</strong> be present concurrently. Finally, the distress from symp<strong>to</strong>ms related <strong>to</strong> <strong>HIV</strong> infectionis often undertreated. It is within this context that symp<strong>to</strong>m assessment must be undertaken<strong>and</strong> each of these fac<strong>to</strong>rs must be taken in<strong>to</strong> consideration within the symp<strong>to</strong>m assessmentprocess.IIISymp<strong>to</strong>ms <strong>and</strong> Quality of Life in Advanced <strong>HIV</strong> InfectionSeveral studies have specifically considered quality of life in people with <strong>HIV</strong> disease. 9-14 <strong>The</strong>impact of symp<strong>to</strong>ms on quality of life was explored in the large prospective cross-sectional surveydone by Vogl, et al. discussed above. 5 In this survey, symp<strong>to</strong>ms were assessed <strong>and</strong> characterizedusing a validated symp<strong>to</strong>m scale <strong>and</strong> it was demonstrated in this population that both thenumber of symp<strong>to</strong>ms <strong>and</strong> the symp<strong>to</strong>m distress were highly associated with psychological distress<strong>and</strong> poorer quality of life. Older age, female sex, nonwhite race, poor social support, <strong>and</strong>the presence of intravenous drug use, each have been associated with greater distress <strong>and</strong> poorerquality of life. In many studies the presence of symp<strong>to</strong>ms is the strongest indica<strong>to</strong>r of poorquality of life. 5, 10, 12, 15 <strong>The</strong> results of these studies highlight the impact of a broad range of physical<strong>and</strong> psychological symp<strong>to</strong>ms on quality of life.THE PRINCIPLES OF SYMPTOM ASSESSMENT■ As discussed above, symp<strong>to</strong>m assessment is a most important aspect of patient care <strong>and</strong> asignificant component of quality of life assessment. 16,17 When care is being provided <strong>for</strong> peoplewith <strong>HIV</strong>-related illness, nearly all clinician interactions with patients require symp<strong>to</strong>m assessmentskills. <strong>The</strong> following section outlines key points <strong>to</strong> consider when assessing symp<strong>to</strong>ms.Definition of the Word Symp<strong>to</strong>mSymp<strong>to</strong>ms are Subjective ExperiencesA symp<strong>to</strong>m has been defined as “a physical or mental phenomena [sic], circumstance or changeof condition arising from <strong>and</strong> accompanying a disorder <strong>and</strong> constituting evidence <strong>for</strong> it.... specificallya subjective indica<strong>to</strong>r perceptible <strong>to</strong> the patient <strong>and</strong> as opposed <strong>to</strong> an objective one (cf.sign).” 18 In other words, symp<strong>to</strong>ms are experienced by the patient <strong>and</strong> signs are observed by theclinician. This is a vital concept; symp<strong>to</strong>ms cannot be seen, although sometimes the physicalmanifestations of a symp<strong>to</strong>m can be detected. Oftentimes a clinician can also observe the distressassociated with a symp<strong>to</strong>m.Symp<strong>to</strong>ms are Different from Pathological Processes or DiagnosesJust as signs are not symp<strong>to</strong>ms, symp<strong>to</strong>ms <strong>and</strong> signs are not, of themselves, diagnoses. Symp<strong>to</strong>ms<strong>and</strong> signs can however assist in the diagnostic process. For example, fatigue is a subjectivesensation–-a symp<strong>to</strong>m–-that may occur with the diagnosis of anemia or infection, but fatigueU.S. Department of Health <strong>and</strong> Human Services • Health Resources <strong>and</strong> Services Administration • <strong>HIV</strong>/<strong>AIDS</strong> Bureau 39

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!